98%
921
2 minutes
20
Background: Cardiovascular disease remains the leading cause of mortality and disability worldwide. Hypercholesterolemia is a significant causal factor of ischemic heart disease, contributing to half of all cardiovascular fatalities.
Methods: This study utilized bibliometric tools to offer a comprehensive overview of the current research trends in hypercholesterolemia. The full records and cited references from 18,641 publications (2003-2023) were retrieved from the Web of Science Core Collection, and bibliometric analysis was conducted using VOSviewer.
Results: The United States and Harvard University had the most significant influence among the countries/regions and research institutions, respectively. Among the researchers, Kastelein J.J.P. published the highest number of related articles, whereas publications by Sabatine M.S. had the highest average citation. The top 10 keywords were atherosclerosis, familial hypercholesterolemia, cardiovascular disease, risk, risk factors, gene expression, coronary heart disease, low-density lipoprotein, statins, and prevalence. These high-frequency keywords were clustered into groups based on the pathogenic mechanisms, disease prevalence and prevention, drugs and treatments, and familial hypercholesterolemia. These clusters denote distinct study fields and current research hotspots for hypercholesterolemia.
Conclusion: Through bibliometric and visual analysis, this study comprehensively assessed global research trends and focal areas within hypercholesterolemia, offering valuable insights into current and future research directions in the field. Further research is needed on the relationship between the intestinal microbiota and cholesterol metabolism and on the advancement of microbiota therapy and precision medicine.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12187739 | PMC |
http://dx.doi.org/10.3389/fcvm.2025.1524697 | DOI Listing |
Life (Basel)
July 2025
University Clinic of Internal Medicine and Ambulatory Care, Prevention and Cardiovascular Recovery, Department VI-Cardiology, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Hypercholesterolemia is a major modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD), affecting a significant proportion of the adult population worldwide. This narrative review provides a comprehensive and up-to-date overview of hyperlipidemia management, spanning from epidemiological trends and underlying pathophysiological mechanisms to the limitations of conventional therapies such as statins and ezetimibe. Particular emphasis is placed on cardiovascular risk assessment, current stratification tools, and international guideline-based interventions.
View Article and Find Full Text PDFBiomedicines
August 2025
Cardiology Department, Regional General Hospital 'F. Miulli', 70021 Acquaviva delle Fonti, Italy.
: High concentration of plasma low-density lipoprotein cholesterol (LDL-C) is the predominant cause of atherosclerotic cardiovascular disease progression and coronary heart disease. Nutraceutical combination together with a cholesterol-lowering action provides an alternative to pharmacotherapy in patients reporting intolerance to statins and in subjects with low cardiovascular risk. The effects on lipid parameters were evaluated over 6 months for a food supplement containing aqueous extract of and , fenugreek seed extract, water/ethanol extract of artichoke leaf and phytosterols from sunflower seeds (Ritmon Colesystem).
View Article and Find Full Text PDFJ Health Popul Nutr
August 2025
Instituto de Investigación de Enfermedades Tropicales, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Perú.
Introduction: Global regional variations in dyslipidemia prevalence underscore the need for an updated global overview of the magnitude of dyslipidemia over time.
Objective: To estimate the global prevalence of dyslipidemia in adults, considering scientific evidence published in the last 20 years, while analyzing associated sociodemographic and geographic factors.
Methodology: A systematic review and meta-analysis were conducted following PRISMA guidelines.
Blood Res
August 2025
Department of Hematology, Zhengzhou University People's Hospital and Henan Provincial People's Hospital, No.7 Weiwu Road, Jinshui District, Zhengzhou City, Henan Province, 450003, People's Republic of China.
Background: Inflammation indices are emerging predictors of diseases. Monoclonal gammopathy of undetermined significance (MGUS) is a precancerous state and chronic inflammation may drive MGUS progression. This study aimed to evaluate the association between inflammatory markers and MGUS.
View Article and Find Full Text PDFHipertens Riesgo Vasc
August 2025
General Director, Asl Napoli 3 Sud, Marconi Street 66, 80059 Torre del Greco, Naples, Italy.
Purpose: Hypercholesterolemia represents a major risk factor in the onset and progression of cardiovascular diseases. While statins have long been the cornerstone of low-density lipoprotein cholesterol (LDL-C) reduction, the occurrence of adverse events associated with their use has prompted the development and adoption of alternative lipid-lowering agents. These include ezetimibe, bempedoic acid, and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, such as alirocumab, evolocumab, and inclisiran.
View Article and Find Full Text PDF